Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy

by Erica B. Flores, Eric Bartee
Published 2020-12-01

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication

by Erica B Flores, Bulent A Aksoy
Published 2020-06-01

Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses.

by Erica B Flores, Mee Y Bartee, Eric Bartee
Published 2020-01-01